Acceleron Pharma
XLRN
#1812
Rank
ยฃ8.20 B
Marketcap
ยฃ134.18
Share price
0.00%
Change (1 day)
14,408.73%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): ยฃ82.52 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is ยฃ84.64 Million. In 2020 the company made a revenue of ยฃ69.45 Million an increase over the revenue in the year 2019 that were of ยฃ55.54 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ82.52 M18.83%
2020ยฃ69.45 M25.05%
2019ยฃ55.54 M428.85%
2018ยฃ10.5 M3.78%
2017ยฃ10.11 M-51.45%
2016ยฃ20.84 M53.47%
2015ยฃ13.58 M23.68%
2014ยฃ10.98 M-74.43%
2013ยฃ42.95 M275.17%
2012ยฃ11.45 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
ยฃ27.00 B 31,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ10.69 B 12,535.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.17 B 81,618.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
ยฃ0.16 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ24.67 M-70.85%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
ยฃ78.02 M-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 55,579.12%๐Ÿ‡บ๐Ÿ‡ธ USA